DTL
XLRN

Dynamic Technology Lab’s Acceleron Pharma XLRN Stock Holding History

Dynamic Technology Lab’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,640
Closed -$331K – 1642
2021
Q2 		$331K Buy
+2,640
New +$333K 0.03% 749
2017
Q4 		– Sell
-13,050
Closed -$487K – 1455
2017
Q3 		$487K Buy
+13,050
New +$453K 0.08% 456
2017
Q2 		– Sell
-10,174
Closed -$269K – 1426
2017
Q1 		$269K Buy
+10,174
New +$268K 0.06% 651

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Dynamic Technology Lab's XLRN Position: Q3 2021 in Review

Dynamic Technology Lab sold out of Acceleron Pharma (XLRN) in Q3 2021, closing a stake of 2,640 shares — an estimated $331K sold.

Dynamic Technology Lab first reported a position in XLRN in Q1 2017 and held it in 3 quarters. The position peaked at $487K in Q3 2017. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

  • Dynamic Technology Lab reported no remaining Acceleron Pharma position as of Q3 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 2,640 Acceleron Pharma shares in Q3 2021, an estimated $331K.
  • Dynamic Technology Lab first reported a position in Acceleron Pharma in Q1 2017 and held it in 3 quarters.
  • Dynamic Technology Lab's Acceleron Pharma position peaked at $487K in Q3 2017.
  • 330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on Dynamic Technology Lab's 13F filing for Q3 2021, filed 15 Nov 2021.